Altimmune
ALT
$7.30
Share price
1.53%
Change (1 day)
46.59%
Change (1 year)
Categories
Altimmune (ALT) - Cash on Hand
Cash on Hand as of December 2023 : $0.19 B
According to Altimmune's latest financial reports the company has $0.19 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Altimmune - Cash on Hand chart (from 2005 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.18 B | -2.85% |
| 2021-12-31 | $0.19 B | -11.87% |
| 2020-12-31 | $0.21 B | 479.81% |
| 2019-12-31 | $37.24 M | 10.44% |
| 2018-12-31 | $33.71 M | 284.5% |
| 2017-12-31 | $8.76 M | 204.91% |
| 2016-12-31 | $2.87 M | -81.53% |
| 2015-12-31 | $15.56 M | -16.49% |
| 2014-12-31 | $18.64 M | 77.88% |
| 2013-12-31 | $10.48 M | -17.48% |
| 2012-12-31 | $12.7 M | 13.04% |
| 2011-12-31 | $11.23 M | -4.65% |
| 2010-12-31 | $11.78 M | 102.82% |
| 2009-12-31 | $5.81 M | -74.67% |
| 2008-12-31 | $22.94 M | -56.49% |
| 2007-12-31 | $52.73 M | 931.58% |
| 2006-12-31 | $5.11 M | 265.63% |
| 2005-12-31 | $1.39 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $95.88 M | -51.53% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.82 M | -89.47% | 🇺🇸 USA |